Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

Wednesday, October 22, 2014 1 min read

Key Takeaway: Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate

Full Press Release Details

Lexicon and Ipsen enter into ex-North America/Japan licensing and commercialization agreement for telotristat etiprate.